Insider Trading & Ownership - Iger Yoni

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Iger Yoni
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-18
Purchase
2021-08-20
7:19 pm
Venus Concept Inc.VEROIger Yoni
VP, RA/QA/Clinical Affairs
5,181$1.94$10,0515,181
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-11-10
Option Award
2022-11-14
5:46 pm
N/A
2032-11-10
Venus Concept Inc.VEROIger Yoni
VP, RA/QA/Clinical Affairs
50,000$050,000
(Direct)
View
2022-03-25
Option Award
2022-03-28
2:38 pm
N/A
2032-03-25
Venus Concept Inc.VEROIger Yoni
VP Scientific Affairs
50,000$050,000
(Direct)
View
2021-03-26
Option Award
2021-08-20
4:15 pm
N/A
2031-03-26
Venus Concept Inc.VEROIger Yoni
VP, RA/QA/Clinical Affairs
70,000$070,000
(Direct)
View
2021-03-26
Option Award
2021-03-30
8:29 pm
N/A
2031-03-26
Venus Concept Inc.VEROIger Yoni
VP, RA/QA/Clinical Affairs
70,000$070,000
(Direct)
View
2020-04-08
Option Award(A)
2020-04-21
4:23 pm
N/A
2030-04-08
Venus Concept Inc.VEROIger Yoni
VP Clinical & Reg. Affairs, QA
25,000$025,000
(Direct)
View
2020-03-30
Option Award
2020-04-01
5:23 pm
N/A
2030-03-30
Venus Concept Inc.VEROIger Yoni
VP Clinical & Reg. Affairs, QA
25,000$025,000
(Direct)
View
2019-11-07
Option Award
2019-11-07
8:59 pm
N/A
2028-09-28
Venus Concept Inc.VEROIger Yoni
VP Clinical & Reg. Affairs, QA
28,834$028,834
(Direct)
View
(A) Indicate amendment filing.